If you are having trouble viewing this email, please view it on our website.

         
 
A Service Announcement from Pharmexec
  Pharmaceutical Representative  
     
 

For information on exhibiting & sponsorship opportunities, please contact Lucas Carrasco at 212-400-6231 or lcarrasco@exlpharma.com

 

CLICK HERE FOR MORE INFORMATION

DOWNLOAD BROCHURE

NEW LEGISLATIVE REQUIREMENTS - Featured Regulatory Perspective
Navigating Vermont's Recently Passed S.88 Bill: The Disclosure and Reporting Process for All Samples Disseminated in Vermont

  • Why you should have already begun tracking your distributed samples
  • How the sample reporting system was deisgned and how it will work
  • Differences between the Vermont law and the Patient Protection & Affordable Care Act of 2010

Wendy Morgan, Assistant Attorney General, VERMONT ATTORNEY GENERAL'S OFFICE

DISTRIBUTION STRATEGY
UCB CASE STUDY

Measuring the Impact of the Sales Force in a Controlled Versus Non-Controlled Regulatory Environment

  • Background, Goals and Structure for the Exercise
    • Balancing business and compliance requirements
    • Successfully identifying and avoiding potential pitfalls
  • Measuring Launch Success
    • Balancing promotion of controlled vs. non-controlled
    • Maximizing AOR completions
    • Analyzing controlled eligible HCPs vs. voucher only States
  • Ongoing Advantages
    • Minimizing sample costs
    • Covering vacant territories and white space
    • Sampling no-see prescribers

James Corbett, Manager, Field Technology, UCB, INC.

Register Now

 

 

 

 

ExL Events
555 8th Avenue #310
New York, NY 10018
Phone: +1 212.400.6240
Email: info@exlpharma.com

If you wish to unsubscribe from future emails from ExL Pharma please email info@exlpharma.com

Pharmaceutical Representative is published by Advanstar Communications, 485 Rt 1 South, Iselin, NJ
This is an advertisement sent on behalf of this advertiser.